BIOGEN INC. of CAMBRIDGE, MA filed a DEFA14A with the SEC on 2023-07-28. Industry: Biological Products, (No Diagnostic Substances).
| Seq | Type | Description |
|---|---|---|
| 1 | DEFA14A | DEFA14A |
| 2 | GRAPHIC | GRAPHIC |
| 3 | GRAPHIC | GRAPHIC |
| 4 | GRAPHIC | GRAPHIC |
| 5 | GRAPHIC | GRAPHIC |
| 6 | GRAPHIC | GRAPHIC |
| 7 | GRAPHIC | GRAPHIC |
| 8 | GRAPHIC | GRAPHIC |
| 9 | GRAPHIC | GRAPHIC |
Showing 12 of 60 filings.
| Filed | Form |
|---|---|
| 2026-04-28 | DEFA14A |
| 2026-04-28 | DEF 14A |
| 2025-06-02 | DEFA14A |
| 2025-04-28 | DEFA14A |
| 2025-04-28 | DEF 14A |
| 2024-04-26 | DEFA14A |
| 2024-04-26 | DEF 14A |
| 2024-04-12 | PRE 14A |
| 2023-07-31 | DEFA14A |
| 2023-07-28 | DEFA14A |
| 2023-06-13 | DEFA14A |
| 2023-06-13 | DEFR14A |